SANTA CLARA, Calif., June 17, 2011 /PRNewswire/ — NewCardio,
Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider,
announced today that Vincent Renz, Chief Executive Officer, is
scheduled to present at the Wells Fargo Securities Healthcare
Conference. The Conference is on June 22 and 23, 2011, at The
InterContinental Boston. Mr. Renz’ presentation is scheduled for
3:30 p.m. ET on Wednesday, June 22.
Investors planning to attend the conference should contact their
Wells Fargo representative to arrange a meeting.
About Wells Fargo
Wells Fargo Advisors is a non-bank affiliate of Wells Fargo
& Company, providing advisory services, asset management,
brokerage services, estate planning strategies, retirement
planning, portfolio analysis and monitoring, and other financial
services through more than 19,000 registered representatives.
Wells Fargo & Company is a nationwide, diversified,
community-based financial services company with $1.2 trillion in
assets. Founded in 1852 and headquartered in San
Francisco, Wells Fargo provides banking, insurance,
investments, mortgage, and consumer and commercial finance through
more than 9,000 stores, 12,000 ATMs, the Internet (wellsfargo.com
and wachovia.com), and other distribution channels across North
America and internationally. With approximately 280,000 team
members, Wells Fargo serves one in three households in
America. Wells Fargo & Company was ranked No. 19
on Fortune’s 2010 rankings of America’s largest
corporations.
About NewCardio, Inc.
NewCardio is a
cardiac diagnostic and services company developing and marketing
proprietary
software platform technologies to provide higher accuracy to,
and increase the value of, the standard 12-lead ECG.
NewCardio’s
‘/>”/>
